Heme and hemoglobin utilization by Mycobacterium tuberculosis
结核分枝杆菌利用血红素和血红蛋白
基本信息
- 批准号:10082420
- 负责人:
- 金额:$ 65.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-01-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityBacteriaBacterial ProteinsBindingBinding ProteinsBiochemicalBiological AssayBiophysicsBiosensorCell surfaceCellsCommunicable DiseasesComplexCryoelectron MicroscopyDataElementsEnvironmentGalliumGeneticGlobinGoalsGranulomaGrowthHemeHeme IronHemoglobinHumanHuman bodyInfectionIronLipid BilayersMembraneMembrane ProteinsMethodsMolecularMusMutateMycobacterium tuberculosisNecrosisPatientsPeptide HydrolasesPorphyrinsProteinsResearch Project GrantsRoleSiderophoresSourceStructureSystemTuberculosisVirulenceX-Ray Crystallographybasecrosslinkexperimental studyheme-binding proteininnovationmacrophagemutantmycobactinsnovelpathogenic bacteriasmall moleculethree dimensional structureuptake
项目摘要
Project Summary - Heme and hemoglobin utilization by Mycobacterium tuberculosis
Mycobacterium tuberculosis (Mtb) is of one of the most important bacterial pathogens. Iron is
essential for growth of Mtb, but iron is efficiently sequestered in the human host. Hemoglobin is
by far the most prevalent iron source in the human body and is often preferred by bacterial
pathogens. Recently, we identified proteins that are essential components of an unprecedented
heme and hemoglobin utilization system in Mtb. Interestingly, these novel heme-binding
proteins are also required for utilization of hemoglobin indicating that heme is released from
hemoglobin at the cell surface of Mtb by an unknown mechanism and then transferred to the
heme uptake system. This proposal aims to elucidate the molecular mechanisms of heme and
hemoglobin utilization by Mtb. This project will lead to a better understanding of how Mtb gains
access to iron during infection. To achieve these goals we employ state-of-the-art genetic,
biochemical, biophysical and structural methods.
结核分枝杆菌对血红素和血红蛋白的利用
结核分枝杆菌(Mycobacterium tuberculosis,Mtb)是最重要的致病菌之一。铁是
铁是结核分枝杆菌生长所必需的,但铁在人类宿主中被有效地隔离。血红蛋白是
到目前为止,铁是人体中最普遍的铁源,
病原体最近,我们发现了一些蛋白质,它们是一种前所未有的
结核分枝杆菌血红素和血红蛋白利用系统有趣的是,这些新颖的血红素结合
血红蛋白的利用也需要蛋白质,这表明血红素是从
血红蛋白通过一种未知的机制在结核分枝杆菌的细胞表面,然后转移到
血红素摄取系统该建议旨在阐明血红素和
结核分枝杆菌血红蛋白利用率该项目将导致更好地了解结核病如何获得
在感染期间获得铁。为了实现这些目标,我们采用了最先进的基因,
生物化学、生物物理和结构方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL NIEDERWEIS其他文献
MICHAEL NIEDERWEIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL NIEDERWEIS', 18)}}的其他基金
Toxin secretion and trafficking by Mycobacterium tuberculosis
结核分枝杆菌的毒素分泌和运输
- 批准号:
10632980 - 财政年份:2023
- 资助金额:
$ 65.05万 - 项目类别:
Siderophore secretion by Mycobacterium tuberculosis
结核分枝杆菌分泌铁载体
- 批准号:
10379326 - 财政年份:2021
- 资助金额:
$ 65.05万 - 项目类别:
Siderophore-dependent inhibitors of Mycobacterium tuberculosis
结核分枝杆菌铁载体依赖性抑制剂
- 批准号:
10199992 - 财政年份:2020
- 资助金额:
$ 65.05万 - 项目类别:
Siderophore-dependent inhibitors of Mycobacterium tuberculosis
结核分枝杆菌铁载体依赖性抑制剂
- 批准号:
10041925 - 财政年份:2020
- 资助金额:
$ 65.05万 - 项目类别:
Heme and hemoglobin utilization by Mycobacterium tuberculosis
结核分枝杆菌利用血红素和血红蛋白
- 批准号:
10320404 - 财政年份:2019
- 资助金额:
$ 65.05万 - 项目类别:
Single-chain MspA for nanopore sequencing of DNA
用于 DNA 纳米孔测序的单链 MspA
- 批准号:
9918943 - 财政年份:2019
- 资助金额:
$ 65.05万 - 项目类别:
Heme and hemoglobin utilization by Mycobacterium tuberculosis
结核分枝杆菌利用血红素和血红蛋白
- 批准号:
10535449 - 财政年份:2019
- 资助金额:
$ 65.05万 - 项目类别:
The necrosis-inducing toxin of Mycobacterium tuberculosis
结核分枝杆菌的坏死诱导毒素
- 批准号:
9178625 - 财政年份:2015
- 资助金额:
$ 65.05万 - 项目类别:
相似国自然基金
Segmented Filamentous Bacteria激活宿主免疫系统抑制其拮抗菌 Enterobacteriaceae维持菌群平衡及其机制研究
- 批准号:81971557
- 批准年份:2019
- 资助金额:65.0 万元
- 项目类别:面上项目
电缆细菌(Cable bacteria)对水体沉积物有机污染的响应与调控机制
- 批准号:51678163
- 批准年份:2016
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Cell Wall Formation in Rod Shaped Bacteria
杆状细菌细胞壁的形成
- 批准号:
BB/Y003187/1 - 财政年份:2024
- 资助金额:
$ 65.05万 - 项目类别:
Research Grant
Did light dictate ancient diversification of phylogeny and cell structure in the domain bacteria?
光是否决定了细菌领域的古代系统发育和细胞结构的多样化?
- 批准号:
24H00582 - 财政年份:2024
- 资助金额:
$ 65.05万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
DNA replication dynamics in living bacteria
活细菌中的 DNA 复制动态
- 批准号:
23K25843 - 财政年份:2024
- 资助金额:
$ 65.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Conference: Symposium on the Immune System of Bacteria
会议:细菌免疫系统研讨会
- 批准号:
2349218 - 财政年份:2024
- 资助金额:
$ 65.05万 - 项目类别:
Standard Grant
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
- 批准号:
EP/Y023528/1 - 财政年份:2024
- 资助金额:
$ 65.05万 - 项目类别:
Research Grant
NPBactID - Differential binding of peptoid functionalized nanoparticles to bacteria for identifying specific strains
NPBactID - 类肽功能化纳米粒子与细菌的差异结合,用于识别特定菌株
- 批准号:
EP/Y029542/1 - 财政年份:2024
- 资助金额:
$ 65.05万 - 项目类别:
Fellowship
Assembly of the matrix that supports bacteria living in biofilms
支持生活在生物膜中的细菌的基质的组装
- 批准号:
2468773 - 财政年份:2024
- 资助金额:
$ 65.05万 - 项目类别:
Studentship
Manipulating two-component systems to activate cryptic antibiotic pathways in filamentous actinomycete bacteria
操纵双组分系统激活丝状放线菌中的神秘抗生素途径
- 批准号:
BB/Y005724/1 - 财政年份:2024
- 资助金额:
$ 65.05万 - 项目类别:
Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
- 批准号:
BB/Y007611/1 - 财政年份:2024
- 资助金额:
$ 65.05万 - 项目类别:
Research Grant
CAREER: Interfacial behavior of motile bacteria at structured liquid crystal interfaces
职业:运动细菌在结构化液晶界面的界面行为
- 批准号:
2338880 - 财政年份:2024
- 资助金额:
$ 65.05万 - 项目类别:
Continuing Grant